154 related articles for article (PubMed ID: 19401587)
21. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
Juergens CP; Winter JP; Nguyen-Do P; Lo S; French JK; Hallani H; Fernandes C; Jepson N; Leung DY
Intern Med J; 2009 Jan; 39(1):25-31. PubMed ID: 18771430
[TBL] [Abstract][Full Text] [Related]
22. Comparison of iodixanol and iohexol in patients undergoing intravenous pyelography: a prospective controlled study.
Chuang FR; Chen TC; Wang IK; Chuang CH; Chang HW; Ting-Yu Chiou T; Cheng YF; Lee WC; Chen WC; Yang KD; Lee CH
Ren Fail; 2009; 31(3):181-8. PubMed ID: 19288321
[TBL] [Abstract][Full Text] [Related]
23. Renal effects of nonionic contrast media after intravenous cardiac, and lumbar aortic injections.
Jakobsen JA; Kolbenstvedt AN; Levorstad K; Berg KJ; Enge I
Invest Radiol; 1990 Sep; 25 Suppl 1():S135-6. PubMed ID: 2283233
[No Abstract] [Full Text] [Related]
24. Clinical and nephrologic tolerance of iopromide and iotrolan in computed tomography.
Langer M; Langer R; Zwicker C; Speck U; Jänicke UA; Felix R
Invest Radiol; 1991 Nov; 26 Suppl 1():S83-5; discussion S88-91. PubMed ID: 1808156
[No Abstract] [Full Text] [Related]
25. No Association between Intravenous Contrast Material Exposure and Adverse Clinical Outcome: Are Prevention Protocols Effective?
Gramberg MC; Penne EL
Radiology; 2015 Oct; 277(1):306. PubMed ID: 26402500
[No Abstract] [Full Text] [Related]
26. Refining the assessment of contrast-induced acute kidney injury: the load-to-damage relationship.
Limbruno U; Picchi A; Micheli A; Calabria P; Cortese B; Brizi G; Severi S; De Caterina R
J Cardiovasc Med (Hagerstown); 2014 Jul; 15(7):587-94. PubMed ID: 23811842
[TBL] [Abstract][Full Text] [Related]
27. Renal effects of cardiac angiography with different low-osmolar contrast media.
Donadio C; Lucchesi A; Ardini M; Tramonti G; Chella P; Magagnini E; Bianchi C
Ren Fail; 2001; 23(3-4):385-96. PubMed ID: 11499554
[TBL] [Abstract][Full Text] [Related]
28. Iso-osmolar radio contrast iodixanol in patients with chronic kidney disease.
Tadros GM; Malik JA; Manske CL; Kasiske BL; Dickinson SE; Herzog CA; Wilson RF; Das G; Panetta CJ
J Invasive Cardiol; 2005 Apr; 17(4):211-5. PubMed ID: 15831975
[TBL] [Abstract][Full Text] [Related]
29. Response.
McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
Radiology; 2015 Oct; 277(1):306-7. PubMed ID: 26668855
[No Abstract] [Full Text] [Related]
30. Response.
McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
Radiology; 2015 Jun; 275(3):931-2. PubMed ID: 26199958
[No Abstract] [Full Text] [Related]
31. Conclusion of recent 'osmolality trials' in preventing contrast-induced nephropathy by NAC--what is the standard?
Jo SH; Koo BK; Youn TJ; Kim HS
Nephrol Dial Transplant; 2008 Jul; 23(7):2424; author reply 2424-5. PubMed ID: 18445639
[No Abstract] [Full Text] [Related]
32. Nephrotoxicity of low-osmolar and iso-osmolar contrast media.
Heinrich M; Uder M
Kidney Int; 2006 Mar; 69(6):1095. PubMed ID: 16528264
[No Abstract] [Full Text] [Related]
33. Iodixanol compared to iohexol for contrast procedures: a case-matched retrospective cohort study.
From AM; Bartholmai BJ; Williams AW; McDonald FS
Acta Radiol; 2008 May; 49(4):409-14. PubMed ID: 18415784
[TBL] [Abstract][Full Text] [Related]
34. Nephropathy induced by contrast medium.
Gruber SJ; Shapiro CJ
N Engl J Med; 2003 May; 348(22):2257-9; author reply 2257-9. PubMed ID: 12773659
[No Abstract] [Full Text] [Related]
35. Effect of intravenous low-osmolality iodinated contrast media on patients with myasthenia gravis.
Somashekar DK; Davenport MS; Cohan RH; Dillman JR; Ellis JH
Radiology; 2013 Jun; 267(3):727-34. PubMed ID: 23360741
[TBL] [Abstract][Full Text] [Related]
36. Nonionic iodinated contrast media reactions.
Lasser EC
AJR Am J Roentgenol; 2009 Feb; 192(2):W80; author reply W81. PubMed ID: 19155387
[No Abstract] [Full Text] [Related]
37. Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration.
Lasser EC; Lyon SG; Berry CC
Radiology; 1997 Jun; 203(3):605-10. PubMed ID: 9169676
[TBL] [Abstract][Full Text] [Related]
38. Contrast-agent-induced acute renal dysfunction--is iodixanol the answer?
Sandler CM
N Engl J Med; 2003 Feb; 348(6):551-3. PubMed ID: 12571263
[No Abstract] [Full Text] [Related]
39. [Reduced risk of nepropathy with isoosmolar contrast media].
Aspelin P
Lakartidningen; 2003 Jun; 100(23):2067-8. PubMed ID: 12833744
[No Abstract] [Full Text] [Related]
40. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Briguori C; Airoldi F; D'Andrea D; Bonizzoni E; Morici N; Focaccio A; Michev I; Montorfano M; Carlino M; Cosgrave J; Ricciardelli B; Colombo A
Circulation; 2007 Mar; 115(10):1211-7. PubMed ID: 17309916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
